Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
Chaolin Huang(Jinyintan Hospital), Bin Cao(Shandong Provincial Hospital), Wen Yin(Central Hospital of Wuhan), Jiaan Xia, Zhancheng Gao(Xiamen University), Yi Hu(Fudan University), Xuelei Xie, Min Liu(China-Japan Friendship Hospital), Jianping Zhao(Xinjiang University), Hui Li(Hebei Food Inspection and Research Institute), Jungang Xie(Huazhong University of Science and Technology), Jiuyang Xu(Tsinghua University), Li Guo(Chinese Academy of Medical Sciences & Peking Union Medical College), Guohui Fan(China-Japan Friendship Hospital), Yuan Wei(James J. Peters VA Medical Center), Jianwei Wang(Zhejiang Cancer Hospital), Li Zhang(Huazhong University of Science and Technology), Xiao Yan(Chinese Academy of Medical Sciences & Peking Union Medical College), Qi Jin(Linyi University), Ting Yu(Chinese Academy of Sciences), Xiaoying Gu(Chinese Academy of Medical Sciences & Peking Union Medical College), Yeming Wang(Chinese Academy of Medical Sciences & Peking Union Medical College), Hong Gao(Institute of Laboratory Animal Science), Zhenshun Cheng(Wuhan University), Xingwang Li(Beijing Ditan Hospital), Wenjuan Wu, Lili Ren(Huaibei Normal University), Rongmeng Jiang(Capital Medical University), Guangfa Wang(Peking University)
Cited by 51,786
Related Papers
Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study
|The Lancet|2020|29.1k
A Trial of Lopinavir–Ritonavir in Adults Hospitalized with Severe Covid-19
|New England Journal of Medicine|2020|5.5k
RETRACTED: 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study
|The Lancet|2021|4.3k
Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial
|The Lancet|2020|3.7k
Risk factors for severity and mortality in adult COVID-19 inpatients in Wuhan
|Journal of Allergy and Clinical Immunology|2020|2.4k